Differential regulation of C3 gene expression in human astroglioma cells by interferon-gamma and interleukin-1 beta

Neurosci Lett. 1995 Sep 8;197(2):121-4. doi: 10.1016/0304-3940(95)11923-k.

Abstract

In this report, we examined interferon-gamma (IFN-gamma) and interleukin-1 beta (IL-1 beta)-mediated regulation of the expression of C3, the third component of complement, in a human astroglioma cell line. Interleukin-1 beta induced C3 protein expression ten-fold more rapidly than IFN-gamma. De novo protein synthesis was required for IFN-gamma to stimulate C3 expression, while cycloheximide and IL-1 beta treatment of cells markedly increased C3 expression. Actinomycin D, inhibited C3 gene induction by IFN-gamma and IL-1 beta suggesting that these cytokines act, in part, at the transcriptional level to enhance C3 expression. Understanding cytokine-mediated regulation of complement gene expression in the astrocyte is important in defining the role of these molecules in CNS inflammation and autoimmune diseases.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Astrocytoma / drug therapy*
  • Astrocytoma / metabolism
  • Astrocytoma / pathology
  • Complement C3 / genetics
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Humans
  • Interferon-gamma / pharmacology*
  • Interleukin-1 / pharmacology*
  • Kinetics
  • Neoplasm Proteins / genetics
  • Transcriptional Activation
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • Complement C3
  • Interleukin-1
  • Neoplasm Proteins
  • Interferon-gamma